Research Article

Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease

Table 3

Clinical characteristics and lab examinations of patients with monoclonal gammopathy.

Laboratory testsMGUSSMMMMAmyloidosisNHLHL value

Age (yr)64.9C13.971.8 ± 11.966.9 ± 12.966.3 ± 11.372.6 ± 9.669 ± 5.30.377
Male n (%)57 (62)4 (57.1)32 (72.7)8 (50)10 (83.3)1 (33.3)0.277
Follow-up (yr)5.4 ± 3.73.6 ± 3.54.4 ± 57.6 ± 5.85.4 ± 5.96.3 ± 3.70.223
White blood cells (±SD) (per mm3)7.5 ± 3.46.3 ± 1.5#6.2 ± 27.1 ± 2.57.6 ± 314.1 ± 16∗,#,†,‡0.006
Hemoglobin (±SD) (gr/dl)11.3 ± 2.512.3 ± 2.710.2 ± 1.612.7 ± 2.011.3 ± 213.3 ± 0.90.002
Platelets (±SD) (per mm3)219 ± 102.6193.2 ± 47.8209 ± 112.3#306.6 ± 154.8∗,#245 ± 39.2188.7 ± 52.60.46
Albumin (±SD) (g/dl)3.1 ± 0.83.6 ± 0.75.4 ± 3∗,#,†2.8 ± 0.73.4 ± 0.6#3.7 ± 0.7<0.001
sCr (±SD) (mg/dl)2.68 ± 2.12.7 ± 2.94.3 ± 2.9∗,#1.4 ± 1#2.4 ± 1.60.93 ± 0.1<0.001
eGFR (±SD) (ml/min)35.2 ± 29.343.5 ± 30.328.4 ± 28.961.6 ± 31.139.9 ± 30.462.7 ± 7.40.004
Ca (±SD) (mg/dl)8.5 ± 18.6 ± 0.8#9 ± 1.1∗,#,†9 ± 2.18 ± 19.6 ± 0.6<0.001
Urine protein-to-sCr ratio (±SD)5.1 ± 6.51.4 ± 1.13.2 ± 4.613.5 ± 7.51.6 ± 2.90.3 ± 0.20.042
Serum M-protein (±SD) (gr/dl)0.6 ± 0.50.8 ± 0.71.12 ± 10.7 ± 0.50.6 ± 0.4NA0.5
FLC k (±SD) (mg/dl)302 ± 177.8228.5 ± 161.5411.5 ± 514.4140 ± 101.5319.3 ± 178.1254 ± 173.10.08
FLC λ (±SD) (mg/dl)172.5 ± 159.3260.6 ± 196.2187.2 ± 231.1200.4 ± 208.7148.8 ± 115.2140.8 ± 117.90.868
Urine M-protein (%)28.271.4100#,∗,†,‡68.7#5033.3<0.001

CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; FLC, free light chain; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; MGUS, monoclonal gammopathy of indeterminate significance; MM, multiple myeloma; M-protein, monoclonal protein; sCr, serum creatinine; SD, standard deviation; SMM, smoldering multiple myeloma. The symbols ∗,#,†, and ‡ indicate statistical significance among the single variables.